Dietary Supplementation with a Low Dose of Finasteride Does Not Alter the Lipid Profile of LDLR-Deficient Mice
May 2020
in “
Current developments in nutrition
”
New to Finasteride? There is a guide in the encyclopedia. Read the guide → 
Studysummary This study found that a low dose of finasteride over 12 weeks did not alter the lipid profile or adiposity index in atheroprone Ldlr−/− mice.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study aimed to investigate whether dietary supplementation with a low dose of finasteride affects the lipid profile in atheroprone Ldlr-deficient mice fed a Western diet. The results showed that 12-week supplementation with a low dose of finasteride did not have a significant impact on food intake, body weight, or adiposity index. There was no significant change in plasma lipids or glucose tolerance. Therefore, the study concludes that finasteride does not have detrimental effects on these metabolic parameters.
